Vision 2030 - Accelerating Saudi Arabia's E​mergence as a Leading Healthcare Innovator

Vision 2030 - Accelerating Saudi Arabia's E​mergence as a Leading Healthcare Innovator 
 

King Abdullah International Medical Research Center in partnership with SABIC is pleased to invite you to attend the upcoming workshop on Healthcare Intellectual Property Awareness: Vision 2030 – Accelerating Saudi Arabia’s Emergence As a Leading Healthcare Innovator that will be held on 20-21 November 2019 in KAIMRC auditorium.

The workshop is dedicated to presenting and discussing the latest developments in the field of Healthcare Intellectual Property, licensing and Biotech and Biopharma Development locally and globally.

The workshop’s program includes international renowned experts such as Walter Klemp, CEO and Chairman, Moleculin Biotech, Inc. and Executive Chairman and Founder, Soliton, Inc, and Gina N. Shishima:  U.S. Head of Intellectual Property, Norton Rose Fulbright US LLP, Olivier Lemaire, Assistant General Counsel, GCC Cluster Legal Director, GlaxoSmithKline and others.

For registration & inquiries, correspond with our team via our email address: biotech-reg@ngha.med.sa

We look forward to your participation in this very important workshop.

Last Modified

12-Nov-2019 04:34 PM